Coverage
-
February 09, 2022
A New York federal judge on Wednesday approved a belated appeal filed by Canadian entities challenging Purdue Pharma's Chapter 11 plan, hours after Purdue said it had no problem with the appeal going forward before the Second Circuit.
9 other articles on this case.
View all »